Literature DB >> 20727625

Magnetic resonance imaging with k-means clustering objectively measures whole muscle volume compartments in sarcopenia/cancer cachexia.

Calum Gray1, Thomas J MacGillivray, Clare Eeley, Nathan A Stephens, Ian Beggs, Kenneth C Fearon, Carolyn A Greig.   

Abstract

BACKGROUND & AIMS: Sarcopenia and cachexia are characterized by infiltration of non-contractile tissue within muscle which influences area and volume measurements. We applied a statistical clustering (k-means) technique to magnetic resonance (MR) images of the quadriceps of young and elderly healthy women and women with cancer to objectively separate the contractile and non-contractile tissue compartments.
METHODS: MR scans of the thigh were obtained for 34 women (n = 16 young, (median) age 26 y; n = 9 older, age 80 y; n = 9 upper gastrointestinal cancer patients, age 65 y). Segmented regions of consecutive axial images were used to calculate cross-sectional area and (gross) volume. The k-means unsupervised algorithm was subsequently applied to the MR binary mask image array data with resultant volumes compared between groups.
RESULTS: Older women and women with cancer had 37% and 48% less quadriceps muscle respectively than young women (p < 0.001). Application of k-means subtracted a significant 9%, 14% and 20% non-contractile tissue from the quadriceps of young, older and patient groups respectively (p < 0.001). There was a significant effect of group (i.e., cancer vs healthy) when controlling for age as a covariate (p = 0.003).
CONCLUSIONS: K-means objectively separates contractile and non-contractile tissue components. Women with upper GI cancer have significant fatty infiltration throughout whole muscle groups which is maintained when controlling for age.
Copyright © 2010 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20727625     DOI: 10.1016/j.clnu.2010.07.012

Source DB:  PubMed          Journal:  Clin Nutr        ISSN: 0261-5614            Impact factor:   7.324


  17 in total

Review 1.  Cancer cachexia, recent advances, and future directions.

Authors:  Marie-France Penet; Zaver M Bhujwalla
Journal:  Cancer J       Date:  2015 Mar-Apr       Impact factor: 3.360

Review 2.  Understanding cancer-induced cachexia: imaging the flame and its fuel.

Authors:  Marie-France Penet; Paul T Winnard; Michael A Jacobs; Zaver M Bhujwalla
Journal:  Curr Opin Support Palliat Care       Date:  2011-12       Impact factor: 2.302

3.  Phase I/II trial of formoterol fumarate combined with megestrol acetate in cachectic patients with advanced malignancy.

Authors:  C A Greig; N Johns; C Gray; A MacDonald; N A Stephens; R J E Skipworth; M Fallon; L Wall; G M Fox; K C H Fearon
Journal:  Support Care Cancer       Date:  2014-01-04       Impact factor: 3.603

4.  Non-invasive quantification of tumour heterogeneity in water diffusivity to differentiate malignant from benign tissues of urinary bladder: a phase I study.

Authors:  Huyen T Nguyen; Zarine K Shah; Amir Mortazavi; Kamal S Pohar; Lai Wei; Guang Jia; Debra L Zynger; Michael V Knopp
Journal:  Eur Radiol       Date:  2016-08-23       Impact factor: 5.315

Review 5.  Assessment of analytical methods used to measure changes in body composition in the elderly and recommendations for their use in phase II clinical trials.

Authors:  M S Lustgarten; R A Fielding
Journal:  J Nutr Health Aging       Date:  2011-05       Impact factor: 4.075

6.  Proteomic identification of potential markers of myosteatosis in human urine.

Authors:  Holger Husi; Alisdair MacDonald; Richard J E Skipworth; Janice Miller; Andrew Cronshaw; Kenneth C H Fearon; James A Ross
Journal:  Biomed Rep       Date:  2018-04-25

7.  Weight loss versus muscle loss: re-evaluating inclusion criteria for future cancer cachexia interventional trials.

Authors:  Eric J Roeland; Joseph D Ma; Sandahl H Nelson; Tyler Seibert; Sean Heavey; Carolyn Revta; Andrea Gallivan; Vickie E Baracos
Journal:  Support Care Cancer       Date:  2016-09-15       Impact factor: 3.603

8.  Genomic and proteomic profiling reveals reduced mitochondrial function and disruption of the neuromuscular junction driving rat sarcopenia.

Authors:  Chikwendu Ibebunjo; Joel M Chick; Tracee Kendall; John K Eash; Christine Li; Yunyu Zhang; Chad Vickers; Zhidan Wu; Brian A Clarke; Jun Shi; Joseph Cruz; Brigitte Fournier; Sophie Brachat; Sabine Gutzwiller; QiCheng Ma; Judit Markovits; Michelle Broome; Michelle Steinkrauss; Elizabeth Skuba; Jean-Rene Galarneau; Steven P Gygi; David J Glass
Journal:  Mol Cell Biol       Date:  2012-10-29       Impact factor: 4.272

9.  Breast cancer-associated skeletal muscle mitochondrial dysfunction and lipid accumulation is reversed by PPARG.

Authors:  Hannah E Wilson; David A Stanton; Stephanie Rellick; Werner Geldenhuys; Emidio E Pistilli
Journal:  Am J Physiol Cell Physiol       Date:  2021-01-13       Impact factor: 4.249

Review 10.  Molecular nutrition research: the modern way of performing nutritional science.

Authors:  Frode Norheim; Ingrid Merethe Fange Gjelstad; Marit Hjorth; Kathrine J Vinknes; Torgrim M Langleite; Torgeir Holen; Jørgen Jensen; Knut Tomas Dalen; Anette S Karlsen; Anders Kielland; Arild C Rustan; Christian A Drevon
Journal:  Nutrients       Date:  2012-12-03       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.